Europe Cardiac Assist Devices Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Product, and Geography

Market Snapshot

Europe Arthroscopy_Picture1
Study Period:

2016-2024

Base Year:

2018

CAGR:

8.5%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Europe Cardiac Assist Devices Market is expected witness a CAGR of 8.5% during the forecast period. Certain factors that are driving the market growth include increasing heart disease prevalence, advancements in technology, and shortage of heart donors in transplantation.

The continuously rapid advancements in the assist devices technologies and the novel applications of the existing treatments have led to an increase in the cardiac assist devices. Engineers are also exploring many other innovative solutions which helps in the implant success and is driving the cardiac assist devices market. Hence, the market is dependent upon the large number of innovations for growth. For instance, the HeartWare left ventricular assist system (LVAS) is an advanced continuous flow device, which has been approved in Europe recently. Other factors responsible for the market growth are lack of donor's hearts for transplantation, aging population, and increasing heart diseases, these factors are leading to the increase in cardiac assist devices implantations in patients with severe heart complications.

However, the cardiac assist devices are highly expensive. The high costs of the devices and the low per capita income in the developing and underdeveloped countries is likely to impede the market of cardiac assist devices in low-income countries. The healthcare facility in these countries is still not well developed and advanced technologies are not affordable for the population owing to the high cost, thereby, restraining the growth of the market. Other factors such as availability of alternative treatments, like pacemakers, and the risk associated with device implantation also hindering the market growth.

Scope of the Report

Cardiac Assist devices are defined as a type of mechanical pumps that work along with the heart to improve the pumping efficiency and maintain optimum blood flow throughout the body.

Product
Intra-Aortic Balloon Pumps
Total Artificial Heart
Ventricular Assist Devices
Left Ventricular Assist Device
Right Ventricular Assist Device
Bi-Ventricular Assist Device
External Ventricular Assist Device
Geography
Europe
Germany
UK
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Total Artificial Heart is Expected to Hold Significant Market Share

The various extracorporeal and ventricular assist devices can only be considered as temporary solutions. The only available option is a total artificial heart. It is considered the best long term solution for patients suffering from advanced heart failure issues.

There are currently, many different types of artificial hearts in the market that are being used: SynCardia temporary total artificial heart, Abiocar replacement heart, and Carmat artificial heart. Thus, these help in driving the market in the region.

Europe Arthroscopy_Picture2

To understand key trends, Download Sample Report

Competitive Landscape

The Europe Cardiac Assist Devices market is highly competitive and consists of a number of major players. Companies like Abiomed, Berlin Heart, CardiacAssist, Inc., Cardiobridge GmbH, Carmat, HeartWare, Jarvik Heart, Inc., XENIOS AG, MiTiHeart Corporation, SynCardia Systems, LLC, among others, hold the substantial market share in the Cardiac Assist Devices market.

Major Players

  1. Abiomed
  2. Berlin Heart
  3. CardiacAssist, Inc.
  4. Cardiobridge GmbH
  5. Carmat

* Complete list of players covered available in the table of contents below

Europe Arthroscopy_Picture4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Heart Disease Prevalence

      2. 4.2.2 Advancements in Technology

      3. 4.2.3 Shortage of Heart Donors in Transplantation

    3. 4.3 Market Restraints

      1. 4.3.1 Expensive Instrument and Maintenance Issues

      2. 4.3.2 Risk Associated with Device Implantation

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product

      1. 5.1.1 Intra-Aortic Balloon Pumps

      2. 5.1.2 Total Artificial Heart

      3. 5.1.3 Ventricular Assist Devices

        1. 5.1.3.1 Left Ventricular Assist Device

        2. 5.1.3.2 Right Ventricular Assist Device

        3. 5.1.3.3 Bi-Ventricular Assist Device

        4. 5.1.3.4 External Ventricular Assist Device

    2. 5.2 Geography

      1. 5.2.1 Europe

        1. 5.2.1.1 Germany

        2. 5.2.1.2 UK

        3. 5.2.1.3 France

        4. 5.2.1.4 Italy

        5. 5.2.1.5 Spain

        6. 5.2.1.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abiomed

      2. 6.1.2 Berlin Heart

      3. 6.1.3 CardiacAssist, Inc.

      4. 6.1.4 Cardiobridge GmbH

      5. 6.1.5 Carmat

      6. 6.1.6 HeartWare

      7. 6.1.7 Jarvik Heart, Inc.

      8. 6.1.8 XENIOS AG

      9. 6.1.9 MiTiHeart Corporation

      10. 6.1.10 SynCardia Systems, LLC

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information